ARTICLE |
|
|
|
|
|
Year : 1991 | Volume
: 33
| Issue : 2 | Page : 104-107 |
A Double-Blind Evaluation of Alprazolam and Imipramine in the Treatment of Major Depression
RS Murthy1, Somanath Chatterjee1, TG Sriram1, LP Shah2, Rajesh Parikh2, S Elavia3, GC Munjal2, Ravi Nehru2, V Ramachandran4, G Nirmala4, KS Raghavan5, V Kumar5
1 Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore 560029, India 2 Department of Psychiatry, K. E.M. Hospital and Seth G. S. Medical College, Mumbai 400012, India 3 Department of Psychiatry, G. B. Pant Hospital, Maulana Azad Medical College, New Delhi-110002, India 4 Department of Psychiatry, Madras Medical College and Government General Hospital, Madras-600001, India 5 Department of Psychiatry, Upjohn International Inc., India Liaison Office, New Delhi, India
Correspondence Address:
R S Murthy Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore 560029 India
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 21897464 
This report describes the results of a multicentre collaborative study comparing the safety and efficacy of alprazolam with imipramine in patients suffering from major depressive disorder. Two hundred and eight patients diagnosed as major depression as per DSM-III criteria were randomly allocated to alprazolam (N= 105) or imipramine (N = 103) in a double-blind fashion. Detailed assessments were carried out for a period of six weeks. Results revealed that alprazolam was as effective as imipramine as an antidepressant. Side effects were less frequently reported with alprazolam.
[PDF]*
|